Cargando…

Biomarker-based early detection of epithelial ovarian cancer based on a five-protein signature in patient’s plasma – a prospective trial

BACKGROUND: Trial on five plasma biomarkers (CA125, HE4, OPN, leptin, prolactin) and their possible role in differentiating benign from malignant ovarian tumors. METHODS: In this unicentric prospective trial preoperative blood samples of 43 women with ovarian masses determined for ovarian surgery we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hasenburg, A., Eichkorn, D., Vosshagen, F., Obermayr, E., Geroldinger, A., Zeillinger, R., Bossart, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447799/ https://www.ncbi.nlm.nih.gov/pubmed/34530759 http://dx.doi.org/10.1186/s12885-021-08682-y

Ejemplares similares

A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium
por: Pils, Dietmar, et al.
Publicado: (2013)

Biomarker-Based Models for Preoperative Assessment of Adnexal Mass: A Multicenter Validation Study
por: Watrowski, Rafał, et al.
Publicado: (2022)

Prognostic Significance of SLFN11 Methylation in Plasma Cell-Free DNA in Advanced High-Grade Serous Ovarian Cancer
por: Tserpeli, Victoria, et al.
Publicado: (2021)

Use of Plasma Metabolomics to Identify Diagnostic Biomarkers for Early Stage Epithelial Ovarian Cancer
por: Fan, Lijun, et al.
Publicado: (2016)

tRNA(GlyGCC)-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression
por: Panoutsopoulou, Konstantina, et al.
Publicado: (2021)

The Long-Term Prognostic Significance of Circulating Tumor Cells in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Definition and Independent Validation of a Proteomic-Classifier in Ovarian Cancer
por: Kasimir-Bauer, Sabine, et al.
Publicado: (2020)

Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer
por: Xie, Hongyu, et al.
Publicado: (2017)

Mining Featured Biomarkers Linked with Epithelial Ovarian CancerBased on Bioinformatics
por: Alur, Varun Chandra, et al.
Publicado: (2019)

Epithelial Ovarian Cancer: A Five Year Review
por: Arnaoutoglou, Christos, et al.
Publicado: (2023)

Five-lncRNA signature in plasma exosomes serves as diagnostic biomarker for esophageal squamous cell carcinoma
por: Jiao, Zichen, et al.
Publicado: (2020)

Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium
por: Obermayr, Eva, et al.
Publicado: (2021)

Artificial Intelligence Based on Blood Biomarkers Including CTCs Predicts Outcomes in Epithelial Ovarian Cancer: A Prospective Study
por: Ma, Jun, et al.
Publicado: (2021)

A five-DNA methylation signature act as a novel prognostic biomarker in patients with ovarian serous cystadenocarcinoma
por: Guo, Wenna, et al.
Publicado: (2018)

Utility Of Plasma circBNC2 As A Diagnostic Biomarker In Epithelial Ovarian Cancer
por: Hu, Yingchao, et al.
Publicado: (2019)

Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome
por: Auer, Katharina, et al.
Publicado: (2015)

A Liquid-Liquid Phase Separation-Related Gene Signature as Prognostic Biomarker for Epithelial Ovarian Cancer
por: Qiu, Yan, et al.
Publicado: (2021)

Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer
por: Aust, Stefanie, et al.
Publicado: (2015)

miRNA-200a/c as potential biomarker in epithelial ovarian cancer (EOC): evidence based on miRNA meta-signature and clinical investigations
por: Teng, Yue, et al.
Publicado: (2016)

A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer
por: Fahrmann, Johannes F., et al.
Publicado: (2021)

Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models
por: Ligat, Laetitia, et al.
Publicado: (2015)

Recent advances in the biomarkers for epithelial ovarian cancer
por: Kim, Yun Hwan, et al.
Publicado: (2011)

Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium
por: Obermayr, Eva, et al.
Publicado: (2017)

High throughput proteomics identifies a high-accuracy 11 plasma protein biomarker signature for ovarian cancer
por: Enroth, Stefan, et al.
Publicado: (2019)

Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer
por: Mungenast, Felicitas, et al.
Publicado: (2017)

Molecular Characterization of Circulating Tumor Cells Enriched by A Microfluidic Platform in Patients with Small-Cell Lung Cancer
por: Obermayr, Eva, et al.
Publicado: (2019)

Comparison of microfluidic platforms for the enrichment of circulating tumor cells in breast cancer patients
por: Sajdik, Constantin, et al.
Publicado: (2022)

Integrative Network Analysis Reveals a MicroRNA-Based Signature for Prognosis Prediction of Epithelial Ovarian Cancer
por: Li, Li, et al.
Publicado: (2019)

Integrative network analysis identifies an immune-based prognostic signature as the determinant for the mesenchymal subtype in epithelial ovarian cancer
por: Sheng, Mingyan, et al.
Publicado: (2020)

Recent developments in cell-based ENS regeneration – a short review
por: Obermayr, Florian, et al.
Publicado: (2018)

ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining
por: Chen, Yanli, et al.
Publicado: (2021)

A Five-Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Tian, Dazhi, et al.
Publicado: (2021)

Prognostic significance of FA score based on plasma fibrinogen and serum albumin in patients with epithelial ovarian cancer
por: Li, Yuan, et al.
Publicado: (2019)

BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer
por: Pilyugin, Maxim, et al.
Publicado: (2021)

Laparoscopic Surgery for Ovarian Neoplasms – What is Possible, What is Useful?
por: Droste, Annika, et al.
Publicado: (2022)

Molecular Signature for Lymphatic Invasion Associated with Survival of Epithelial Ovarian Cancer
por: Paik, E Sun, et al.
Publicado: (2018)

A novel immune-related prognostic signature in epithelial ovarian carcinoma
por: Su, Tong, et al.
Publicado: (2021)

A Five-Gene Expression Signature Predicts Clinical Outcome of Ovarian Serous Cystadenocarcinoma
por: Liu, Li-Wei, et al.
Publicado: (2016)

Plasma‐based microRNA signatures in early diagnosis of breast cancer
por: Li, Xu, et al.
Publicado: (2020)

Multi-biomarker panel signature as the key to diagnosis of ovarian cancer
por: Muinao, Thingreila, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5rgl68h5sc9jnsqm9ego7qfkqh